Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
• PRODUCT 1
Quant (Derivatives) Pick
Intraday Positional Underlying Action
Voltas Buy
Dabur Buy
Buy ITC JAN Fut at | 242.50-243.00 ITC 245.5 249.6 240.0 Intraday Duration : 1-3 months
Sell UJJFIN JAN Fut at | 331.00-332.00 UJJFIN 327.8 322.1 335.3 Intraday
Click here to see open calls
• PRODUCT
For Instant stock ideas:2
SUBSCRIBE to mobile notification
on ICICIdirect Mobile app…
Research Analysts
Amit Gupta Raj Deepak Singh
amit.gup@icicisecurities.com rajdeepak.singh@icicisecurities.com
Index Outlook
Nifty Future: The Nifty is likely to open gap down on the back of negative global cues. Sell Nifty in the range of 12278-
Derivatives View
12300 Target: 12262-12235 Stop loss: 12317
Bank Nifty Future
After opening near 32000, Call writing was clearly visible for a major part of the day. The index tested its highest Put base
of 31000 in intraday. Selling pressure was seen in private and PSU banks. Looking at the current OI set-up in select private
banks, we feel the index may slide further once it move below 31000. Sell Bank Nifty in the range of 31300-31350, Target:
31200-31000 Stop loss: 31450
F&O Highlights
The Nifty finally paused its upward move and ended with loss of 128 points. Profit booking was seen from 12400, where
most of the pain was seen in index heavyweights like Reliance Industries, HDFC Bank and Kotak Mahindra Bank. However,
on the weekly option front, Call writing was seen at the 12300 strike that may act as a hurdle on upsides. If any intraday
pullback is seen towards 12300, it can be utilised to sell at higher levels
0
Note: The given index recommendation in
11500
11600
11700
11800
11900
12000
12100
12200
12300
12400
200
50
100
150
200
250
300
350
400
450
50
0
1-Jan-18 1-Jan-18
1-Mar-18 1-Mar-18
1-Jul-18 1-Jul-18
1-Sep-18 1-Sep-18
1-Nov-18 1-Nov-18
1-Jan-19 1-Jan-19
ITC
1-Mar-19 1-Mar-19
Ujjivan Financial
1-May-19 1-May-19
1-Jul-19 1-Jul-19
Recommended Stocks : Historical price performance…
1-Nov-19
1-Nov-19
1-Jan-20
1-Jan-20
4
Buy Lupin (LUPIN) January future in range of | 765-770. Target: | 850; Stop Loss: | 725
Derivatives View
Rationale
Pharma stocks have been witnessing renewed buying recently while the NSE Pharma index has moved to its highest levels since
May 2019. We believe the ongoing momentum in the space may continue while stocks with high short build-up are likely to
witness short covering. Lupin is one such stock that has seen short addition of almost 20% in the ongoing series. Among Call
strikes, closure of positions is already visible at ATM and OTM strikes while the highest Call base of 790 strike is witnessing
closure. We expect the ongoing momentum to continue in the coming sessions.
Price performance
1200
1000
600
400
200
17-Jul-19
17-Jan-18
17-Jul-18
17-Aug-18
17-Dec-18
17-Jan-19
17-Aug-19
17-Dec-19
17-Jan-20
17-Feb-18
17-Apr-18
17-Feb-19
17-Apr-19
17-Oct-18
17-Nov-18
17-Oct-19
17-Mar-18
17-May-18
17-Mar-19
17-May-19
17-Nov-19
17-Sep-18
17-Sep-19
17-Jun-18
17-Jun-19
Recommendation follow up
Underlying View Strategy Reco Target Stoploss Profit/Loss Comment
Asian Paints Bullish Long Futures 1800 1870 1740 28800 Profit Booked
• After four weeks of consolidation below 12300, the Nifty finally ended above the level. A gradual and consolidated move towards
12600 is expected in the coming weeks. However, some volatility may be seen near expiry. The Put base has become higher at
12200 while it would remain a support on any intermediate decline
• Call positions have been the highest at 12500 since the start of the series with additions seen even at the 12600 strike. These would
be the Nifty target levels
• Volatility has been on an upward bias as we are moving into Budget. This week also it reverted from lower levels of 12.5% to 14%.
The hurdle for volatility is placed at 16% from where it should again start reverting lower, thus keeping the overall bias of the equity
index positive
• The Nifty is getting support from non-banking heavyweights from the cement, metals, pharma, FMCG and auto pack, which is also
keeping the momentum intact in the broader market. We believe midcaps from these sectors would remain in the limelight even in
25
20
15
10
5
0
11800 11900 12000 12100 12200 12300 12400 12500 12600
• On the back of global jitters, volatility remained high in the currency market. Due to this, movement was seen on both sides in
the banking and financial space. The OI declined in the past few days as the Bank Nifty moved towards the lowest level of the
series. However, it reverted from its highest Put base of 31000
• PSU banks remained under pressure but participation continued in private banks, which provided cushion. Stocks like HDFC
Bank and Axis Bank are likely to perform well from the current levels, which will pull the index higher
• The highest Put base is placed at 31500 and 31000 whereas a close above 32000 would trigger fresh upsides. Recently, yields
had moved up due to higher inflation. Later, it was supported by a surge in crude oil prices. With crude seemingly making a top
near $72, we also expect limited upsides in yields. This should bode well for the banking space
• The current price ratio of the Bank Nifty/Nifty fell towards 2.55. We feel that once the index manages to end above 32000,
outperformance can be seen in the banking space, which will pull the ratio higher towards 2.60
800
OI in Thousands
600
400
200
0
31300
31400
31500
31600
31700
31800
31900
32000
32100
32200
32300
32400
32500
Source: Bloomberg, ICICI Direct Research
January 21, 2020 ICICI Securities Ltd. | Retail Equity Research 7
FII flows in India remain muted despite broad market rally…
• EM markets witnessed mixed flows during the week after an easing of Middle East tensions and signing of a trade deal between the
US and China. South Korea saw highest inflows among emerging markets with almost $ 390 million in the week. India has not seen
any major flows last week. It saw outflow of $20.7 million. Taiwan and Indonesia saw inflows of $176 and $41 million, respectively,
while Philippines saw outflows of $ 23 million
• FIIs have remained net positive till now in January and bought almost | 2040 crore in Indian equities. In the F&O space, they sold
stock futures worth $149 million while they sold index futures to the tune of $66 million last week
• After witnessing the sharpest decline in almost a year, Brent has been consolidating at lower levels and remained below 65 levels.
We do not expect it to test $70 once again, which should be positive for emerging market economies like India. FII flows are likely to
resume in the coming sessions ahead of the Union Budget
• Higher-than-expected inflation numbers have put bond yields under pressure while 10 year yields have moved above 6.60 despite
Call OI Put OI
8
250
In 000's
7.5
200
US$INR Options OI
150
6.5 100
6 50
Sep-19
Dec-19
Dec-19
Feb-19
Jan-19
Jan-19
Jun-19
Oct-19
Oct-19
Jan-20
May-19
May-19
Nov-19
Jul-19
Jul-19
Aug-19
Mar-19
Mar-19
Apr-19
73.5
70.00
70.50
71.00
71.50
72.00
72.50
73.00
Source: Bloomberg, ICICI Direct Research
January 21, 2020 ICICI Securities Ltd. | Retail Equity Research 9
Forthcoming Events…
India:
Japan:
US:
Euro zone:
27-Dec-19 REC Ltd Buy Positional Option: Buy REC Ltd January 145 Call at 3.3-3.8; Target: 8; Stop loss: 0.9; Time Frame: Till January expiry
10-Jan-20 Vedanta Buy Long/Short Strategy : Bull Call Spread: Buy Vedanta Ltd Jan 165 Call at 4.50-4.90 and Sell Vedanta 180 Call at 1.40-1.60. Target: 180; Time Frame: Till January expiry
Date Scrip Action Buy Price Target SL CMP %Ret Time Frame
23-Oct-19 Voltas Buy 685-700 815 630 700 0.0% 3 months
31-Oct-19 Exide Industries Buy 186-191 230 171 195 2.7% 3 months
05-Nov-19 Dabur India Buy 465-475 550 432 486 2.3% 3 months
13-Jan-20 Hindustan Unilever Buy 1940-1970 2285 1775 2063 4.7% 3 months
16-Jan-20 Pidilite Industries Buy 1410-1440 1670 1290 1440 0.0% 3 months
We /I, Amit Gupta B.E, MBA (Finance), Raj Deepak Singh BE, MBA (Finance), Nandish Patel BCOM, Dipesh Dedhia BCOM, MBA (Finance), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this
research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Analysts are not registered
as research analysts by FINRA and are not associated persons of the ICICI Securities Inc. It is also confirmed that above mentioned Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve
months and do not serve as an officer, director or employee of the companies mentioned in the report.
ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial products. ICICI Securities Limited is a SEBI registered Research Analyst with SEBI
Registration Number – INH000000990. ICICI Securities Limited SEBI Registration is INZ000183631 for stock broker. ICICI Securities is a subsidiary of ICICI Bank which is India’s largest private sector bank and has its various subsidiaries engaged in businesses of
housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. (“associates”), the details in respect of which are available on www.icicibank.com
ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship with a significant percentage of
companies covered by our Investment Research Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover.
Recommendation in reports based on technical and derivative analysis centre on studying charts of a stock's price movement, outstanding positions, trading volume etc as opposed to focusing on a company's fundamentals and, as such, may not match with the
recommendation in fundamental reports. Investors may visit icicidirect.com to view the Fundamental and Technical Research Reports.
Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein.
ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Retail Research. The views and opinions expressed in this document may or may not match or may be contrary
with the views, estimates, rating, target price of the Institutional Research.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in
any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis,
ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been
suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances.
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational
purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings,
corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its associates or its analysts did not receive any compensation or other benefits from the companies
mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of interest at the time of publication of this report.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
ICICI Securities or its subsidiaries collectively or Research Analysts or their relatives do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report.
Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report.
ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.
We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law,
regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in
whose possession this document may come are required to inform themselves of and to observe such restriction.